Pharmacokinetic properties and bioequivalence of two formulations of arbidol: An open-label, single-dose, randomized-sequence, two-period crossover study in healthy chinese male volunteers
- Resource Type
- Article
- Source
- In
Clinical Therapeutics April 2009 31(4):784-792 - Subject
- Language
- ISSN
- 0149-2918